Finerenone's Role in Heart Failure from ESC Congress Data
02 September 2024

Finerenone's Role in Heart Failure from ESC Congress Data

Don't Miss a Beat

About
Live from ESC Congress 2024!



In this edition of Don’t Miss a Beat, Stephen Greene, MD, an advanced heart failure specialist at Duke University School of Medicine, discusses the prospect of finerenone in treatment algorithms for heart failure with Muthiah Vaduganathan, MD, MPH, codirector of the Center for Cardiometabolic Implementation Science of Brigham and Women’s Hospital, based on data from the meeting, including FINEARTS-HF, FINE-HEART, and an analysis on MRA use in heart failure.



Chapters



00:00 - Welcome and Introduction

01:18 - FINEARTS-HF Study Design and Patient Population

03:04 - Inclusion of Hospitalized Patients

04:43 - Primary and Secondary Endpoints

05:56 - Challenges in Achieving Statistical Significance

07:39 - Health Status Improvement and Additional Analyses

10:01 - Combination Therapy and Future Trials

12:20 - Hyperkalemia and Steroidal vs. Non-Steroidal MRAs

15:30 - Conclusion and Acknowledgments